N-(4-(Piperazin-1-ylsulfonyl)phenyl)acetamide

Catalog No.: 
ACPIPB556
CAS No.: 
100318-71-6
Molecular Formula: 
C12H17N3O3S
Molecular Weight: 
283.35
N-(4-(Piperazin-1-ylsulfonyl)phenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$155.00InquiryInquiry
1g95%$388.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-(Piperazin-1-ylsulfonyl)phenyl)acetamide
IUPAC NameN-(4-(piperazin-1-ylsulfonyl)phenyl)acetamide
MDL No.MFCD04113956
Molecular FormulaC12H17N3O3S
Molecular Weight283.35
SMILESCC(NC1=CC=C(S(=O)(N2CCNCC2)=O)C=C1)=O
InChI KeyHMBMCJNYWPOZKR-UHFFFAOYSA-N
SynonymN-[4-(1-;N-[4-(1-piperazinylsulfonyl)phenyl]acetamide;N-(4-(Piperazin-1-ylsulfonyl)phenyl)acetaMide;N-(4-piperazin-1-ylsulfonylphenyl)ethanamide;Acetamide, N-[4-(1-piperazinylsulfonyl)phenyl]-
CAS No.100318-71-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPIPB556 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPIPB556 route product structure diagram
    ACPIPB556100318-71-6
Inquiry

2. ACPIPB556 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPIPB556 route product structure diagram
    ACPIPB556100318-71-6
Inquiry

3. ACPIPB556 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPIPB556 route product structure diagram
    ACPIPB556100318-71-6
Inquiry

Comments (0)